Cargando…
DNA CpG methylation in sequential glioblastoma specimens
PURPOSE: Glioblastoma is the most aggressive form of brain tumors. A better understanding of the molecular mechanisms leading to its evolution is essential for the development of treatments more effective than the available modalities. Here, we aim to identify molecular drivers of glioblastoma devel...
Autores principales: | Kraboth, Zoltan, Galik, Bence, Tompa, Marton, Kajtar, Bela, Urban, Peter, Gyenesei, Attila, Miseta, Attila, Kalman, Bernadette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519911/ https://www.ncbi.nlm.nih.gov/pubmed/32779022 http://dx.doi.org/10.1007/s00432-020-03349-w |
Ejemplares similares
-
Epigenetic Suppression of the IL-7 Pathway in Progressive Glioblastoma
por: Tompa, Marton, et al.
Publicado: (2022) -
Involvement of the Catecholamine Pathway in Glioblastoma Development
por: Kraboth, Zoltán, et al.
Publicado: (2021) -
Longitudinal Characteristics of Glioblastoma in Genome-Wide Studies
por: Kraboth, Zoltan, et al.
Publicado: (2019) -
ß-Adrenoreceptors in Human Cancers
por: Kraboth, Zoltan, et al.
Publicado: (2023) -
Epigenetic mechanisms of lung carcinogenesis involve differentially methylated CpG sites beyond those associated with smoking
por: Petrovic, Dusan, et al.
Publicado: (2022)